3
Co Located Conferences
300+
Companies
400+
Senior Pharma Leaders

 


Part of the Biopharma Development & Production Week (BDP), IBC’s 7th Annual Biomanufacturing Conference provides a timely platform for industry experts to have in-depth discussions on new biomanufacturing technologies, latest regulations, and ways to improve the speed, cost, quality of your process development and manufacturing efforts. Gain insights from top CMOs and Pharma on their challenges, learnings and strategies to improve competitiveness in this evolving industry.

“Valuable, world-class and professionally-organized, this conference was among the very best I've ever attended.”
Peter Fuhrman, Chairman & Chief Executive Officer, China First Capital


 

Key Highlights

60+
sessions
70+
Senior Biopharmaceutical Speakers
New Investment
Outlook and partnership opportunities
Facility Innovations
In design, technology and flexibility
cGMP and Quality
Case Studies on effective and proactive systems
Regulatory Compliance
Strategies through operational control and audits


Featured Speakers

Zhihao (Peter) Qiu
Branch Chief, Division of Inspectional Assessment, Office of Process and Facilities, Office of Pharmaceutical Quality, CDER, US FDA

Tao Tong Jing
Senior Director Quality Assurance, Tasly Pharmaceutical, China

Peter Shen
Vice President, Process Development and Manufacturing, WuXi AppTec, China

Frank Ye
Head of Manufacturing, JUST Biotherapeutics, China

Michael Lee
Project Director, BeiGene Biopharmaceutical, China

Weichang Zhou
Chief Technology Officer and Senior Vice President, Biologics Development and Manufacturing, WuXi Biologics, China 

Claudia Lin
General Manager, Alphamab Co. Ltd, China

Scott Wheelwright
CEO, Complya Asia Co. Ltd., China


View Our Past Reviews

“Valuable, world-class and professionally-organized, this conference was among the very best I've ever attended.”

Peter Fuhrman, Chairman & Chief Executive Officer, China First Capital

“The IBC Asia event was well organized and thought out. It attracted thought leaders not just from Asia but from all over the world, to share their knowledge and experience on addressing current bio pharma industry challenges.”

Jenifer L. Wheat, Vice President Global Business Development, Samsung BioLogics Co., Ltd. 

“Good meeting! Benefits from aggregating the 3 streams for plenary, added value for participants.”

David Hughes, CEO, Biopharmaceuticals, Australia

“Well organized, expanding the vision of the bio industry in different countries in Asia. “

Jinhua Zhang, Business Development Director, Livzon MabPharm

 

Part of

Co-Located Events

Contact Us

Produced by

Platinum Sponsor

Gold Sponsors

Bronze Sponsor

Associate Sponsor

Exhibitors

Media Partners

International Marketing Partner